We observe that whilst A2AR expression is elevated in activated tumor antigen-specific CD8+ T cells in the DLN, A2AR expression is fairly ubiquitous amongst CD8+ T cell sub-populations within the tumor, regardless of their antigen specificity or differentiation status. Here, ADORA2A is linked to neoplasm.